Markets:

Overview

News

Currencies

International

Treasuries

CareDx, Inc. - Common Stock (NQ:CDNA)

19.47 +1.12 (+6.10%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

CareDx to Report Second Quarter 2023 Financial Results

August 03, 2023

From CareDx, Inc.

Via Business Wire

CareDx’s HeartCare Multimodality Service Receives Medicare Coverage for Heart Transplant Surveillance

August 02, 2023

From CareDx, Inc.

Via Business Wire

CareDx Acquires MediGO, an Organ Transplant Supply Chain and Logistics Company

July 25, 2023

From CareDx, Inc.

Via Business Wire

CareDx Applauds District Court Decision to Uphold Jury Verdict that Natera Falsely Advertised its Prospera Transplant Test

July 17, 2023

From CareDx, Inc.

Via Business Wire

CareDx’s AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring

July 11, 2023

From CareDx, Inc.

Via Business Wire

CareDx Demonstrates Innovation Leadership at 2023 Transplant Congress

June 01, 2023

From CareDx, Inc.

Via Business Wire

CareDx to Participate in Upcoming Investor Conferences

June 01, 2023

From CareDx, Inc.

Via Business Wire

CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management Forum

May 16, 2023

From CareDx, Inc.

Via Business Wire

CareDx Reports First Quarter 2023 Results

May 10, 2023

From CareDx, Inc.

Via Business Wire

CareDx to Report First Quarter 2023 Financial Results

May 08, 2023

From CareDx, Inc.

Via Business Wire

CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference

April 25, 2023

From CareDx, Inc.

Via Business Wire

CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation

April 19, 2023

From CareDx, Inc.

Via Business Wire

National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant Community

April 06, 2023

From CareDx, Inc.

Via Business Wire

CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation

April 05, 2023

From CareDx, Inc.

Via Business Wire

CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation

April 05, 2023

From Miromatrix Medical Inc.

Via GlobeNewswire

CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association

March 23, 2023

From CareDx, Inc.

Via Business Wire

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

March 10, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

The American Society of Transplant Surgeons Position Statement Supports Use of CareDx’s AlloSure Kidney for Organ Transplant Surveillance

March 07, 2023

From CareDx, Inc.

Via Business Wire

CareDx Update Regarding Raymond James & Associates’ Conference

March 06, 2023

From CareDx, Inc.

Via Business Wire

CareDx To Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference

March 06, 2023

From CareDx, Inc.

Via Business Wire

CareDx Comments on MolDX Publication of New Billing and Coding Article

March 03, 2023

From CareDx, Inc.

Via Business Wire

CareDx Key Supporter of the National Kidney Foundation’s Annual Kidney Patient Summit

March 01, 2023

From CareDx, Inc.

Via Business Wire

CareDx Reports Fourth Quarter and Full Year 2022 Results

February 27, 2023

From CareDx, Inc.

Via Business Wire

CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting

February 22, 2023

From CareDx, Inc.

Via Business Wire

CareDx to Report Fourth Quarter and Full Year 2022 Financial Results

February 21, 2023

From CareDx, Inc.

Via Business Wire

CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem Meetings

February 16, 2023

From CareDx, Inc.

Via Business Wire

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

February 13, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice

January 26, 2023

From CareDx, Inc.

Via Business Wire

CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium

January 11, 2023

From CareDx, Inc.

Via Business Wire

CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022

January 09, 2023

From CareDx, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

CareDx, Inc. - Common Stock (NQ:CDNA)

Press Releases about CareDx, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today